|
If
you encounter problems viewing this email go to http://www.publicforuminstitute.org/nde/news/nde-news.htm
|
|

|
April 23 - 29, 2007
|
|
Innovations in Community
Development Venture Capital
Over the past few years, the
community development venture capital (CDVC) movement has been growing
by leaps and bounds. CDVC funds operate much like traditional venture
capital funds, but are designed with the purpose of pursuing a “double
bottom line.” They seek to make money for investors while also promoting
social equity and community development. The latest issue of Community
Developments Investments, a journal sponsored by the Office of the
Comptroller of the Currency, reviews what’s been happening in the CDVC
field. The issue looks at various CDVC models and also profiles some
model programs run by Wells Fargo and by the Kentucky Highlands
Investment Corporation.
Access the Spring 2007 issue of Community Developments Investments,
entitled “Community
Development Venture Capital: A Catalyst for Double Bottom-Line Results.”
|
|
Embracing Open Innovation in
Europe
The European Union continues to crank out research examining how to
build a stronger innovation economy. The latest missive concerns
knowledge transfer policies. In a report released earlier this month,
the Commission of the European Communities presents a series of policy
proposals to ease the transfer of knowledge from research institutions
to private industry. The report contains a review of many ongoing
initiatives across Europe. Its big recommendation calls for the creation
of a European Institute of Technology (EIT). This concept was first
introduced in 2005, but the EU now hopes to have an operational EIT in
2008. Under the EIT umbrella, a host of targeted “Knowledge and
Innovation Communities” will seek to build closer research alliances
between academia, business, and the public sector. The report also
recommends that member states devote more resources to supporting
knowledge transfer between researchers and small and medium-sized
enterprises.
Access the April 4, 2007 Commission of the European Communities report,
“Improving
Knowledge Transfer Between Research Institutions Industry across Europe:
Embracing Open Innovation.”
|
|
Small Business Share of GDP,
1998-2004
A new research study sponsored by the US Small Business Administration’s
Office of Advocacy seeks to quantify the contribution of small business
to the American economy. According to the research, small businesses
accounted for half of non-farm gross domestic product between 1998 and
2004. This overall level held steady throughout the period, but the
importance of small business contributions varies greatly by industrial
sector. Two sectors – construction and other services – are very small
business intensive, with small firms accounting for eighty percent of
the economic contribution of the industries. Not surprisingly, more
capital intensive sectors of the economy (mining, utilities, and
manufacturing) have small business shares that are smaller than average.
Download the April 2007 US Small Business Administration Office of
Advocacy-sponsored report,
The Small
Business Share of GDP, 1998-2004, by Katherine Kobe.
|
|
Invent Now
The US Patent
and Trademark Office, along with the Advertising Council and the
National Inventors Hall of Fame, has recently unveiled an exciting new
initiative to get kids excited about invention and innovation. InventNow
targets 8-11 year olds with an exciting media campaign and programs that
seek to interest kids in using their imaginations to produce tomorrow’s
technological innovations. InventNow has developed a series of public
service announcements to be used on TV, radio, the web, and on outdoor
advertising. InventNow also sponsors a web page with lots of interesting
games and activities for kids.
To learn more, visit
www.inventnow.org.
|
|
Bio-Pharma in Massachusetts
A new report
from Massachusetts profiles the emerging alliance between biotech and
pharmaceutical firms in the Bay State. As one of the US’s leading life
sciences centers, Massachusetts serves as a bellwether for new trends in
the industry – and business is still pretty good. While Massachusetts
lags other states in terms of life sciences job creation, the state
still leads in key areas such as per capita venture capital investment,
employee wages, and federal investments. The report profiles an emerging
and interesting trend of closer partnerships between large
pharmaceutical firms and new biotech companies. As drug development
costs skyrocket, biotechs are reaching out to big Pharma to help close
the funding gap. The study highlights 357 such partnerships (with a
value of $13.4 billion) in Massachusetts alone. If the state wants to
maintain this strong bio-pharma industry, it needs to address the key
business challenges identified by industry leaders. These problem areas
include, among others: a shortage of affordable workforce housing, high
costs of doing business, and a real-estate permitting process that is
too slow and cumbersome.
Download the April 11, 2007 report, “A
Critical Alliance: The Biotechnology and Pharmaceuticals Industries in
Massachusetts,” prepared for the Massachusetts High Technology
Council by the UMASS Donahue Institute.
|
|
The National Dialogue
on Entrepreneurship is an initiative of the Public Forum Institute made
possible by a grant from the Kauffman
Foundation of Kansas City. Through NDE-news, we bring you short
summaries and analyses of various trends driving entrepreneurship around
the world.
Subscribe now to receive your weekly copy.
Archived issues are available online.
|
|

|
National Dialogue on Entrepreneurship 
|
|
All
stories © 2007 The Public Forum Institute
Content from this newsletter may be reproduced for non-commercial
purposes with proper attribution to the National Dialogue on
Entrepreneurship and a link to www.publicforuminstitute.org/nde.
|